Response by Khosravani et al to Letter Regarding Article, "Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic"

High Yield of Pharmacogenetic Testing for Clopidogrel Resistance in a Canadian Outpatient Stroke Population.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026

Use of Telestroke Prior to Endovascular Stroke Treatment in Canada: Results from the OPTIMISE Registry.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026

CRCS-K Imaging Repository: Architecture, Data Characteristics, and a Proof-of-Concept Analysis of Pretreatment Imaging Workflow.

Journal of the American Heart Association·2026

Cost-effectiveness of Tenecteplase Versus Alteplase for Acute Ischemic Stroke in Canada Based on the AcT Trial.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026

The granular Hypoperfusion Intensity Ratio (gHIR): A Novel Perfusion-Weighted Metric to Assess the Cerebral Infarct Growth Rate.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026

In-hospital intracerebral hemorrhage: A comprehensive characterization of a provincial cohort.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026

Initial Direct Oral Anticoagulants Versus Warfarin After Cerebral Venous Thrombosis: A Target Trial Emulation.

Stroke·2026

Racial Disparities in Longitudinal Functional Outcome After Ischemic Stroke.

Stroke·2026

Multiomics Profiling Supports Cathepsin B as a Protective Factor in White Matter Hyperintensities and Cognition.

Stroke·2026

Health Literacy and Communication in Stroke Prevention, Management, and Recovery: A Scientific Statement From the American Heart Association.

Stroke·2026

Clinical Outcome Differences in Asia Versus Non-Asia Intracerebral Hemorrhage: IPD Analysis From BP-Lowering Clinical Trials.

Stroke·2026

David G. Sherman Lecture: The Eternal Quest for Optimal Stroke Prevention.

Stroke·2026

Correction: Implementation of guideline-recommended organ-protective therapy in people with type 2 diabetes and cardiovascular disease, heart failure, or kidney disease: real-world evidence from a German University Hospital.

Frontiers in endocrinology·2026

Integration of hereditary thrombophilia data and polygenic risk scores into prognostic models improves differential diagnosis of CTEPH.

Frontiers in cardiovascular medicine·2026

Hybutimibe, an innovative cholesterol absorption inhibitor for lipid-lowering therapy: current evidence and future perspectives.

Frontiers in pharmacology·2026

Beyond traditional anticoagulants: exploring the future of thromboembolism treatment with FXI inhibitors.

Frontiers in immunology·2026

Living with angina: rethinking angina management in ANOCA through lived experience.

Frontiers in cardiovascular medicine·2026

Association of early neutrophil-to-lymphocyte ratio trajectories with cardiac recovery and live ICU discharge in patients with sepsis-induced cardiomyopathy: a retrospective cohort study.

Frontiers in medicine·2026

Related Experiment Videos

Response by Khosravani et al to Letter Regarding Article, "Protected Code Stroke: Hyperacute Stroke Management During

Related Concept Videos

High Yield of Pharmacogenetic Testing for Clopidogrel Resistance in a Canadian Outpatient Stroke Population.

Use of Telestroke Prior to Endovascular Stroke Treatment in Canada: Results from the OPTIMISE Registry.

CRCS-K Imaging Repository: Architecture, Data Characteristics, and a Proof-of-Concept Analysis of Pretreatment Imaging Workflow.

Cost-effectiveness of Tenecteplase Versus Alteplase for Acute Ischemic Stroke in Canada Based on the AcT Trial.

The granular Hypoperfusion Intensity Ratio (gHIR): A Novel Perfusion-Weighted Metric to Assess the Cerebral Infarct Growth Rate.

In-hospital intracerebral hemorrhage: A comprehensive characterization of a provincial cohort.

Initial Direct Oral Anticoagulants Versus Warfarin After Cerebral Venous Thrombosis: A Target Trial Emulation.

Racial Disparities in Longitudinal Functional Outcome After Ischemic Stroke.

Multiomics Profiling Supports Cathepsin B as a Protective Factor in White Matter Hyperintensities and Cognition.

Health Literacy and Communication in Stroke Prevention, Management, and Recovery: A Scientific Statement From the American Heart Association.

Clinical Outcome Differences in Asia Versus Non-Asia Intracerebral Hemorrhage: IPD Analysis From BP-Lowering Clinical Trials.

David G. Sherman Lecture: The Eternal Quest for Optimal Stroke Prevention.

Correction: Implementation of guideline-recommended organ-protective therapy in people with type 2 diabetes and cardiovascular disease, heart failure, or kidney disease: real-world evidence from a German University Hospital.

Integration of hereditary thrombophilia data and polygenic risk scores into prognostic models improves differential diagnosis of CTEPH.

Hybutimibe, an innovative cholesterol absorption inhibitor for lipid-lowering therapy: current evidence and future perspectives.

Beyond traditional anticoagulants: exploring the future of thromboembolism treatment with FXI inhibitors.

Living with angina: rethinking angina management in ANOCA through lived experience.

Association of early neutrophil-to-lymphocyte ratio trajectories with cardiac recovery and live ICU discharge in patients with sepsis-induced cardiomyopathy: a retrospective cohort study.

Related Experiment Videos

Response by Khosravani et al to Letter Regarding Article, "Protected Code Stroke: Hyperacute Stroke Management During...

Related Concept Videos

Related Articles

Response by Khosravani et al to Letter Regarding Article, "Protected Code Stroke: Hyperacute Stroke Management During